Showing results (381-390 of 447) with videos related to

Sort By:
Pageof 45
Environmental Science and Pollution Research International|January 18, 2015
Differential gene transcription, biochemical responses, and cytotoxicity assessment in Pacific oyster Crassostrea gigas exposed to ibuprofenMiguel A S Serrano, Maria Gonzalez-Rey, Jacó J Mattos, et al.
Clinical Proteomics|June 22, 2011
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersBryan T Hennessy, Yiling Lu, Ana Maria Gonzalez-Angulo, et al.
Breast Cancer Research : BCR|July 12, 2014
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancerPatrick C O'Leary, Marta Terrile, Malgorzata Bajor, et al.
Journal for Immunotherapy of Cancer|July 24, 2026
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trialMaria Gonzalez-Cao, Marta Sisteré-Oró, Teresa Moran, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
Genes|April 28, 2023
Molecular and Sociodemographic Colorectal Cancer Disparities in Latinos Living in Puerto RicoJulyann Perez-Mayoral, Maria Gonzalez-Pons, Hilmaris Centeno-Girona, et al.
Blood Advances|June 17, 2026
KIT mutation and AHN-associated oncogenic profiles in systemic mastocytosis with an associated hematological neoplasmPaula Navarro-Navarro, Carlos Maria Fernandez Gimenez, Andrés C García-Montero, et al.
Cancer Research|August 5, 2008
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancerKatherine Stemke-Hale, Ana Maria Gonzalez-Angulo, Ana Lluch, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Predicting Recanalization Failure With Conventional Devices During Endovascular Treatment Related to Vessel OcclusionAlan Flores, Marcos Elizalde, Laia Seró, et al.
Nature Communications|December 2, 2021
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trialMaria Gonzalez-Cao, Clara Mayo de Las Casas, Juana Oramas, et al.
Pageof 45